Publications

유방암 검진 권고안 개정안 = The Korean guideline for breast cancer screening

Full metadata record

DC Field Value
dc.contributor.author이은혜
dc.contributor.author박보영
dc.contributor.author김남순
dc.contributor.author서현주
dc.contributor.author고경란
dc.contributor.author민준원
dc.contributor.author신명희
dc.contributor.author이기헌
dc.contributor.author이시연
dc.contributor.author최나미
dc.contributor.author허민희
dc.contributor.author김동일
dc.contributor.author김민정
dc.contributor.author김성용
dc.contributor.author선우성
dc.contributor.author당지연
dc.contributor.author김수영
dc.contributor.author김열
dc.contributor.author이원철
dc.contributor.author정준
dc.date.accessioned2017-01-25T04:09:11Z
dc.date.available2017-01-25T04:09:11Z
dc.date.issued2015-05-31
dc.identifier.issn1975-8456
dc.identifier.urihttps://repository.kihasa.re.kr/handle/201002/24996
dc.description.abstractBreast cancer is the second most common malignancy among Korean women. The 2002 National Cancer Center screening guideline breast cancer was revised via an evidence-based approach to provide medical personnel with a standard protocol of screening breast cancer. There is moderate-level evidence that biennial screening mammography in asymptomatic women aged 40 to 69 reduces breast cancer mortality, while low-level evidence suggests that screening mammography in women 70 years or older does not reduce breast cancer mortality. The committee concluded that the current evidence is insufficient to assess the benefits and harms of either ultrasonography or clinical breast examination as screening modalities for breast cancer. Future researches about the benefits and harms of the National Breast Cancer Screening Program in Korea are strongly required because the characteristics of breast cancer in Korea are different from those in the West, especially regarding dense breast. In conclusion, the committee recommends biennial screening mammography in asymptomatic women aged 40 to 69 years (grade B recommendation). The committee recommends selective screening mammography in women 70 years or older according to individual risk and preference (grade C recommendation). The committee neither recommends nor opposes ultrasonography and clinical breast examination as screening modalities (grade I recommendation). Symptomatic and high-risk women, however, should be offered complementary measures including ultrasonography and clinical breast examination under clinical supervision.
dc.format.extent12
dc.languagekor
dc.publisher대한의사협회
dc.title유방암 검진 권고안 개정안
dc.title.alternativeThe Korean guideline for breast cancer screening
dc.typeArticle
dc.type.localArticle(Academic)
dc.identifier.apprname학술논문평가
dc.subject.keywordBreast neoplasms
dc.subject.keywordMass screening
dc.subject.keywordGuideline
dc.subject.keywordMammography
dc.subject.keyword유방암
dc.subject.keyword선별검사
dc.subject.keyword권고안
dc.subject.keyword유방촬영술
dc.contributor.affiliatedAuthor김남순
dc.identifier.doi10.5124/jkma.2015.58.5.408
dc.identifier.urlhttps://doi.org/10.5124/jkma.2015.58.5.408
dc.citation.title대한의사협회지
dc.citation.volume58
dc.citation.number5
dc.citation.startPage408
dc.citation.endPage419
dc.identifier.bibliographicCitation대한의사협회지, vol. 58, no. 5, pp. 408 - 419
메타데이터 간략히 보기

링크

공유

qrcode
공유하기

아이템 조회 수, 다운로드 수

Loading...

라이선스

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.